SCHEMBL7672291

SCHEMBL7672291

SCCOc1ccc(Br)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
DRD4 P21917 2/20 0.47
DRD2 P14416 1/20 0.47
DRD3 P35462 1/20 0.47
LMNA P02545 1/20 0.46
MAOB P27338 2/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LTA4H P09960 1/20 0.46
PTGS2 P35354 1/20 0.46
MAPK1 P28482 1/20 0.44
NSD2 O96028 1/20 0.44
NSD3 Q9BZ95 1/20 0.44
APP P05067 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891033 0.87 HDAC3 (0.52) KDM4EALDH1A1L3MBTL1LTA4HHDAC3
SCHEMBL6557649 0.85 MAOB (0.57) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL18235025 0.82 DRD4 (0.57) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL17445905 0.82 ATM (0.60) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL14031270 0.80 TSHR (0.58) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL7898603 0.80 ATM (0.58) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL17465617 0.80 ATM (0.58) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL6570979 0.80 APP (0.47) KDM4EALDH1A1DRD4DRD2DRD3
SCHEMBL31201179 0.78 KDM4E (0.48) KDM4EL3MBTL1MAPK1APPHDAC3
SCHEMBL1697534 0.78 KDM4E (0.50) KDM4EALDH1A1DRD4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed